glp-1 houston Here's how many Americans say they are now taking drugs GLP-1 Hair Loss: 7 Effective

Progression of tubulointerstitial fibrosis and the chronic kidney disease phenotypeRole of risk factors and epigenetics

PLoS ONE 8:e61965

Clinical studies on neuroprotection of GLP-1RAs After numerous preclinical studies have examined the neuroprotective effects of GLP-1RAs, new clinical trials have been initiated

If we are willing to step beyond traditional abstinence-based paradigms, GLP-1RAs may pave the way for a more inclusive, effective, and pragmatic approach to reducing alcohol-related harm

doi: 10.1210/jcem.86.5.7463 [DOI] [PubMed] [Google Scholar] 197

A meta-analysis of clinical trials, including data from Novo Nordisk itself, found higher incidence of optic ischemic neuropathy in GLP-1 groups compared to placebo